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MMPI-2 DETECTION STRATEGIES
outlined detection strategies relevant to malingering on the MMPI-2 that were tested with multiple measures across both simulation designs and knowngroup comparisons. In particular, MMPI-2 feigning indexes use the following strategies: (a) rare symptoms, (b) symptom severity, (c) obvious versus subtle symptoms, and (d) symptom selectivity. Additional strategies have also been implemented, most notably erroneous stereotypes (Gough, 1954; Rogers & Bender, in press) .
A robust detection strategy for feigned mental disorders is the use of rare symptoms. Rare symptoms refer to symptoms, characteristics, or associated features of impaired functioning that occur very infrequently in genuinely impaired populations. On the MMPI-2, rare symptoms might be defined as "atypical characteristics as-The Minnesota Multiphasic Personality Inventory-2 (MMPI-2) is the most extensively researched psychological measure of feigned mental disorders. Several dozen investigations have examined the effects of feigning, primarily under analogue conditions, with comparisons of simulators to mentally disordered samples. These studies are heterogeneous, reflecting important differences in feigning indexes, types of feigned disorders, and simulation designs.
Meta-analyses with the MMPI (Berry, Baer, & Harris, 1991) and the MMPI-2 (Rogers, Sewell, & Salekin, 1994) have catalogued the range of available feigning indexes. In many cases, individual investigators have proliferated new indexes with apparently little attention to the underlying detection strategies. The next section reviews MMPI-2 feigning indexes with respect to their implicit detection strategies. sociated with psychopathology or impairment that are not commonly endorsed by clinical populations." The implicit logic of rare symptoms is that malingerers are unlikely to differentiate very infrequent symptoms from their more common counterparts.
The rare-symptoms strategy is used by the following MMPI-2 feigning indexes: F (Infrequency), Fb (Back Infrequency), and Fp (Infrequency-Psychopathology). As reported in Table 1 , Fb is particularly vulnerable to yeasaying with 92.5% "true" responses. Strictly speaking, the development of F and Fb was flawed from a rare-symptoms perspective because their development involved only normative samples of presumably unimpaired participants. Items that are rare in a normative sample may be more common in a clinical population. As a case in point, 15 or more F items are endorsed by 25% of clinical samples (Greene, 1997) . The development of Fp (Arbisi & Ben Porath, 1995) sought to remedy this oversight by identifying symptoms rarely endorsed by genuine patients. As a possible complication, Fp includes four infrequent items from Scale L (Lie); whether their inclusion impedes interpretation is worthy of further investigation (see Gass & Luis, 2001) .
A second detection strategy examines symptom severity. Symptom severity considers the number of potentially disabling symptoms and characteristics endorsed by genuine patients versus malingerers. This strategy is operationalized on the MMPI-2 in the form of "critical items." The implicit strategy is based on the premise that some malingerers will not take into account symptom severity and will endorse an unexpectedly high number of critical items. Most MMPI-2 malingering research is based on the Lachar and Wrobel (1979) critical items (i.e., LW), representing 14 areas of psychological concern.
A third detection strategy involves the comparison of obvious and subtle symptoms. Obvious symptoms refer to items clearly indicative of major psychopathology, whereas subtle symptoms refer to those not typically recognized as such by nonprofessionals. The implicit strategy capitalizes on malingerers' tendency to recognize and endorse more obvious than subtle symptoms. 1 Although several methods have been tested (Greene, 2000) , current research has focused on the Wiener and Harmon obvioussubtle subscales (Wiener, 1948) . A potential limitation of this strategy is the difficulty in selecting subtle symptoms that are relevant to mental disorders but appear to be unrelated. On this point, Bagby, Nicholson, and Buis (1998) marshaled data in support of using obvious symptoms alone. However, most research has continued to focus on the relationship between obvious and subtle symptoms.
Beyond the Rogers (1997) detection strategies for feigned mental disorders, the MMPI and MMPI-2 use an innovative strategy, namely, erroneous stereotypes. Gough (1954) identified MMPI items, based on common misperceptions about neuroticism and maladjustment, that were inaccurately perceived by both professionals and nonprofessionals. These items cover a broad content including somatic complaints, dysphoria, discontent about childhood, sexual conflicts, and bizarre ideation. The implicit strategy rests on the inability of malingerers to differentiate erroneous stereotypes from genuine psychopathology. On the MMPI-2, Gough's dissimulation scale (Ds) and an abbreviated version (Ds-Revised or Dsr) employ erroneous stereotypes. Although originally developed to examine feigned neurosis, these scales have utility with a wide range of disorders. Beyond Gough's work, Lees-Haley, English, and Glenn (1991) developed the Fake-Bad Scale (FBS) to assess erroneous stereotypes and (Caldwell, 1998) , whereas second correlations are based on the normative sample (Butcher, Dahlstrom, Graham, Telelgen, & Kaemmer, 1989 atypical symptoms specifically related to personal injury cases. Several potential detection strategies have yet to be rigorously tested. For example, Greene (1997) has proposed a bipolarity hypothesis with malingering and defensiveness (i.e., marked underreporting or denial of psychopathology) representing opposite poles. If correct, malingerers could potentially be identified by the absence of defensiveness. The implicit strategy is that malingerers will focus on the production of bogus symptoms and remain incognizant of the need to report some characteristics of defensiveness. An early MMPI-2 study by Graham, Watts, and Timbrook (1991) found suppressed scores on K for both male (M = 35.8T) and female (M = 32.7T) simulators. Another potential MMPI-2 strategy, successful with other measures, is symptom selectivity. The implicit strategy is based on the notion that some malingerers will indiscriminately endorse items associated with psychopathology. Problems with symptom selectivity are likely to be reflected in extreme profile elevations (Dahlstrom, Welsh, & Dalhstrom, 1972) . Recently, Wetter and Deitsch (1996) found that simulators of post-traumatic stress disorder (PTSD) produced extreme profile elevations for both original (M = 84.72) and retest (M = 80.67) administrations. Both absence of defensiveness and symptom selectivity require further investigation as potential MMPI-2 detection strategies. Berry et al. (1991) performed the first malingering meta-analysis that was based on the original MMPI. Their review compiled 28 studies representing a broad array of nonclinical and clinical samples. Unfortunately, more than one third of these studies did not include clinical samples, thereby limiting the relevance of their findings. In general, Berry et al. (1991) found the largest effect sizes for F, Ds, and F-K. The most effective cut scores for MMPI feigning indexes were difficult to establish because studies varied so widely in their proposals.
PREVIOUS META-ANALYSES AND THE CURRENT STUDY
Fundamental changes between the MMPI and the MMPI-2 necessitated a reevaluation of validity indexes for feigning. Rogers et al. (1994) examined 14 MMPI-2 feigning studies. As a modification of the Berry et al. (1991) design, effect sizes for feigned versus patient samples were calculated separately. Very large (d ≥ 1.75) effect sizes 2 were found for F, F-K (raw score difference of Infrequency-Correction), and O-S (T score difference of Obvious-Subtle), paralleling Berry et al. for the first two estimates. Insufficient studies reported Ds, but effect sizes for Dsr were large (i.e., mean d = 1.54). Like Berry et al., cut scores were widely scattered across studies. For example, cut scores derived from individual studies for F ranged markedly from 8 to 29.
The current study is designed to update the Rogers et al. (1994) meta-analysis and improve its methodology. In the past 8 years, the number of MMPI-2 malingering studies has more than doubled; clearly, the effect sizes need to be recalculated in light of these new data. Methodologically, past meta-analyses were forced by the paucity of specific studies to combine data across all simulation conditions and clinical groups. A critical issue is whether MMPI-2 fake-bad indexes are equally effective across different diagnostic groups. For example, do cut scores and effect sizes work equally well for patients presenting with PTSD and schizophrenia? In addition, most MMPI-2 feigning studies appear to use samples of convenience. To broaden the generalizability of the current meta-analysis, we augmented the MMPI-2 feigning research with data on validity scales from other recent studies using clinical populations with specific diagnoses.
METHOD
The basic design for this meta-analysis is modeled after Berry et al. (1991) and Rogers et al. (1994) . In keeping with Rogers et al. (1994) , we separately examined effect sizes for (a) simulators versus presumably healthy controls and (b) simulators versus patient groups. Because differences between simulators and controls may reflect genuine psychopathology, the latter analysis is more relevant. As a further refinement, effect sizes were also calculated on the basis of litigation status and well-represented diagnostic groups.
Compilation of MMPI-2 Studies
We conducted a PsychInfo search from 1989 (i.e., the publication date of the MMPI-2) through September 2002. We reviewed all abstracts for the MMPI-2 related to the following terms: malingering, faking, feigning, fake-bad, and dissimulation. To provide additional clinical samples for specific disorders, MMPI-2 abstracts related to diagnosis were examined. We also reviewed the most recent issues of major assessment journals (i.e., Assessment, Journal of Personality Assessment, and Psychological Assessment) for studies not yet reported in PsychInfo.
An a priori decision addressed research designs for the classification of MMPI-2 feigning. Feigning groups were included if they were derived from either known-groups comparisons or simulation designs. Some investigations attempted to use the differential prevalence design, hypothesizing that clinical groups might vary according to the referral question (e.g., forensic vs. nonforensic) in the proportion (i.e., prevalence) of malingering. Because group membership cannot be determined by this design, their data were not included in the calculation of effect sizes for feigning groups. Research studies were also excluded that did not provide the necessary clinical data (i.e., Ms and SDs for validity scales). Logically, group data were also excluded for participants in experimental conditions for other response styles (e.g., defensiveness and random responding).
Calculation of Effect Sizes and Other Estimates
An important objective of the study was the ability to make direct comparisons with earlier meta-analyses. In line with Berry et al. (1991) and Rogers et al. (1994) , Rosenthal's (1984) formula was calculated: d = (M f -M h ) ÷ SD p . In defining terms, M f = the mean of feigning group scores, M h = the mean of groups under honest (standard) instructions, and SD p = the pooled standard deviation of the two groups.
Effect sizes were calculated individually for each study on all available feigning indexes. To minimize coding errors, a researcher cross-checked the entered data (Ms and SDs) with published tables. To eliminate computational errors, the effect sizes were computed in Excel via the above formula. Effect sizes were also calculated across studies to evaluate the relative usefulness of specific MMPI-2 validity scales for the determination of feigning.
In line with past research, descriptive data on cut scores were assembled. These data include individual cut scores, their hit rates, and the total number of studies and participants used in their development. Because many recent studies do not include cut scores, we also report Ms and SDs by clinical groups with sufficient representation (i.e., ns > 100). This information provides psychologists with the option of calculating z scores in estimating the likelihood of feigning versus nonfeigning.
RESULTS
A total of 62 MMPI-2 feigning studies were compiled that provided criterion groups with sufficient descriptive data (ns, Ms, and SDs) for computing effect sizes. However, 18 studies relied entirely on a differential prevalence design and were used only to calculate diagnostic data and differences due to (a) litigation or (b) group status (e.g., child custody vs. patient). These feigning studies were augmented with 11 MMPI-2 diagnostic studies that were added to increase the patient samples. Table 2 summarizes the 73 studies used in this meta-analysis, including descriptions of the samples, design, and type of instructions.
Effect sizes for individual studies are described in Table  3 . Studies vary dramatically regarding which MMPI-2 scales are used and what types of comparisons are conducted. In addition to feigning indexes, a minority of studies reported standard validity scales for defensiveness, namely, Scales L and K. We included these scales in Table  3 in order to examine the absence of defensiveness as a potential detection strategy for MMPI-2 feigning.
An important issue is whether specific MMPI-2 validity scales vary substantially when administered to different diagnostic groups. As noted in Table 4 , several scales (O-S mean d = 3.04; F-K mean d = 2.44) had very large effect sizes for different diagnoses. Psychologists must take this variability into account when evaluating response styles for certain diagnostic groups with moderate elevations.
Psychologists are often concerned about the potential effects of litigation on response styles. The differences on MMPI-2 feigning indexes due to litigation are only modest, ranging from .03 to .83 (see Table 4 ). Surprisingly, the effect sizes are substantially lower for litigation (mean d = .43) than the differences found across diagnoses (mean d = 1.31).
Comparisons of feigners and presumably healthy control groups yielded very large effect sizes (mean d= 2.48) for most MMPI-2 feigning indexes. The only major exception was the Subtle scale (mean d = .35). In stark contrast, three scales evidenced extremely large effect sizes: F (mean d = 4.05), Obvious (mean d = 3.57), and Fb (mean d = 3.46) scales. The overall results do not address the crucial issue of evaluating differences between bogus and genuine patients. Instead, they raise important methodological concerns that feigning-control comparisons may provide highly inflated effect sizes.
The paramount comparison for feigning studies is the examination of all simulators versus all genuine patients. Under nearly all circumstances, psychologists have no reliable data regarding which mental disorders a particular person is likely to feign. Many would-be malingerers are poorly informed about diagnostic information and may have only vague objectives when dissimulating (e.g., appear grossly impaired). Moreover, many patients have a complicated diagnostic presentation that is not represented by a single disorder. Given the lack of specific presentations for both feigners and genuine patients, we believe that a heterogeneous sampling of both response styles is likely to provide the best basis for comparison.
Several robust validity scales are related to three detection strategies, namely, rare symptoms, erroneous stereotypes, and obvious-subtle symptoms. For the raresymptoms strategy, the two scales produced very large effect sizes, namely, F (mean d = 2.21) and Fp (mean d = 1.90). These results indicate the robustness of the raresymptoms strategy and support its routine use for the MMPI-2 assessment of feigning. The slightly larger mean effect size for F versus Fp was surprising, given the refinements in Fp item selection that specifically differentiate genuine patients from feigners. Erroneous-stereotypes strategy is a sophisticated method for the detection of feigned mental disorders. As summarized in Table 4 , the full Ds scale produced a large effect size (mean d = 1.62) that appears slightly larger than the briefer Dsr (mean d = 1.49). In addition, two MMPI-2 validity indexes, O-S and Obvious, demonstrate the usefulness of the obvious-subtle strategy in evaluating feigned psychological impairment. Clearly, the "Obvious" Shores & Carstairs (1998) ST 18 NOTE: Samples were the following: IP = inpatient, OP = outpatient, ST = student, CV = community volunteers, CC = child custody, PR = prisoners, FIP = forensic inpatients, VIP = VA inpatients, VOP = VA outpatients, and EX = experts. Responses were the following: H = Honest (i.e., groups under standard instructions) and F = Fake (i.e., groups under feigning instructions). Specifically, 1H = control or nonclinical sample, 1F = faking global impairment (i.e., "fake-bad" instructions). Diagnoses were the following: 2 = schizophrenia, 3 = depression, 4 = post-traumatic stress disorder (PTSD), 5 = borderline personality, 6 = bipolar, 7 = mixed diagnoses, 8 = substance abuse, 9 = psychosis, 10 = cognitive impairment, 11 = chronic pain, 12 = personal injury/workers' comp, 13 = eating disorder. Lit = litigants. Comparison types were 1 = simulators versus normals, 2 = simulators versus patients, 3 = patients versus patients, 4 = repeated measures (same sample with administration under different conditions), 5 = simulators versus other simulators, and 6 = litigants versus patients/other litigants. NR = not reported; NA = not applicable. a. Overall means and percentages reported before group assignment/identification. b. Data taken from VA sample by Arbisi and Ben-Porath (1995 (mean d = 2.03) has a much greater effect than the "Subtle" (mean d = .68) component of this subtraction. While Obvious appears very promising, its results are concentrated on a few studies from two research programs (see Table 3 ). Despite lower effect sizes (mean d = 1.51), psychologists may wish to continue using O-S because of its extensive research with clinical comparisons for 11 studies and a total of 1,403 participants. Recent investigations underscore psychologists' concerns that MMPI-2 validity scales may have only limited applicability to certain diagnostic groups. The primary concern is whether specific disorders result in highly elevated feigning indexes. To address this issue, Table 5 reports descriptive data on five diagnostic categories: schizophrenia, depression, PTSD, cognitive impairment, and mixed diagnoses. Using one standard deviation above the mean as a convenient benchmark, patients with genuine schizophrenia may have extreme elevations 3 on F (M + 1 SD = 103.30), Fb (M + 1 SD = 103.62) and marked elevations on Fp (M + 1 SD = 86.80). In addition, patients with genuine depression have the possibility of extreme elevations on F (M + 1 SD = 93.27) and Fb (M + 1 SD = 106.14). Wetter, Baer, Berry, Robison, & Sumpter (1993) ( Moreover, patients with genuine PTSD produce slightly higher elevations than the other diagnostic groups with the possibility of very extreme elevations on Fb (M + 1 SD = 116.86) and extreme elevations on F (M + 1 SD = 107.89) and lower but extreme elevations on Fp (M + 1 SD = 90.02).
Concerns have been raised about the effects of cognitive impairment on MMPI-2 profile validity (e.g., Mittenberg, Tremont, & Rayls, 1996; Youngjohn, Davis, & Wolf, 1997) . As observed in Table 5 , only scale Fb produces a moderate likelihood of an extreme elevation (M + 1 SD = 90.89) as a result of cognitive impairment. In contrast, the F scale has the likelihood of a moderate elevation (M + 1 SD = 78.52), whereas Fp falls clearly in the average range (M + 1 SD = 58.10). Although concerns are likely to continue about clinical interpretations with cognitively impaired patients (Gass & Wald, 1997) , the Fp scale appears to work especially well with this population.
Many recent studies have omitted cut scores for MMPI-2 feigning indexes. On one hand, these omissions are understandable in light of the highly divergent results re-ported in past meta-analyses (Berry et al., 1991; Rogers et al., 1994) . On the other hand, the absence of optimized cut scores militates against a systematic analysis of feigning indexes across simulation studies. We address cutting scores from two perspectives (see Table 6 ). First, we summarized cut scores from feigning studies, similar to past meta-analyses. These data include the optimal cut scores, the number of studies, and the overall hit rates. Second, we adopted a normative approach to ensure that few genuine patients were misclassified as feigning. For the normative approach, we calculated the 98th percentile (z = 2.06) for the entire patient sample included in the meta-analysis. For purposes of comparison, we also provided Greene's (2000) compilation of patient data from Caldwell (1998) for the 98th percentile. As summarized in Table 6 , normatively based cut scores are only useful with very extreme elevations. This observation is especially true for F, Fb, and O-S. For the rare-symptoms strategy, a strong positive finding was for Fp with strongly convergent data for cut scores, spanning both individual studies and normative compilations. The Ds scale is distinguished from all other MMPI-2 validity scales by the remarkable consistency in published cut scores with six studies using Ds > 35 raw and the seventh study using its T-score equivalent for men. Although its overall classification rate is somewhat lower (76%), avoiding the marked range in cut scores plainly outweighs this limitation. Equally impressive, Caldwell's normative data yield the same cut score (Ds > 35) that also minimizes false-positives with the current normative data (see Table  6 ). A slightly higher cut score (Ds > 99T) would reduce further the possibility of the false-positives for problematic diagnoses, such as PTSD and schizophrenia. NOTE: C = optimal cut score; # = number of simulation studies; % = the overall classification rates. All research and normative cut scores should be considered close approximations because of rounding. F = Infrequency; Fb = Back Infrequency; F-K = raw score difference of Infrequency-Correction; Fp = Infrequency-Psychopathology; O-S = T score difference of Obvious-Subtle; Ds = Dissimulation; Dsr = Dissimulation-Revised; LW = Lachar-Wrobel. a. Cut scores are approximate because of T to raw score transformations. b. Approximately r22 for men and r20 for women. c. Approximately r18 for men and r19 for women. d. Approximately r8 for men and r9 for women. e. Approximately r32 for men and r34 for women. f. Caldwell normative data are provided at the 98th percentile (i.e., cut scores at this level would result in ≤ 2% of presumably genuine patients being misclassified as feigning).
TABLE 5 Descriptive Data (M and SD) for Specific Diagnoses for Presumptively Genuine Patients

TABLE 6 Cut Scores for Minnesota Multiphasic Personality Inventory-2 (MMPI-2) Feigning Indexes
F Fb F-K Fp O-S Dsr Ds LW C (#) % C (#) % C (#) % C (#) % C (#) % C (#) % C (#) % C (#) % r15(
Unweighted Mean Cut Scores for Reported Studies in the Current Meta-Analysis
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DISCUSSION
Effectiveness of Detection Strategies and Scales
Butcher and Williams (1992) advocated the use of two standard MMPI validity scales (i.e., F and Fb) for the evaluation of feigned profiles. As found in the current metaanalysis across all simulators and genuine patients (see Table 4 ), F has a very large effect size (mean d = 2.21) in contrast to Fb (mean d = 1.62). The current data suggest a reconsideration of Butcher and Williams's recommendations. Both F and Fb capitalize on the identical scale development (normative item selection) and detection strategy (rare symptoms). Beyond its redundancy with and lower effect sizes than F, Fb appears vulnerable to the misclassification of genuine patients. Employing the earlier benchmark (M + 1 SD), extreme elevations (i.e., > 100T) are anticipated in a substantial minority of genuine patients with schizophrenia, depression, and PTSD. Therefore, the routine use of Fb runs the risk of more falsepositives than F but is unlikely to add incremental validity.
An important consideration is whether the MMPI-2 Fp should be selected as the primary rare symptoms strategy. In a straightforward comparison of effect sizes, the Fp (mean d = 1.90) produces a slightly lower effect size than F. On a conceptual basis, however, the Fp was designed to assess differences between genuine disorders and feigning. In contradistinction, F is a normatively developed scale that simply measures divergence from normality but does not necessarily distinguish genuine from feigned abnormality. This key difference in scale development is likely responsible for the corresponding differences in clinical elevations. For example, patients with PTSD have marked elevations on F (M = 86.31) compared with moderate elevations on Fp (M = 69.02). The comparative advantages of F and Fp will be revisited with reference to cut scores.
A second detection strategy that warrants close attention is erroneous stereotypes. A large effect size was found for Ds in evaluating erroneous stereotypes (mean d = 1.62) for all patients versus all feigners (see Table 4 ). The Ds scale appears particularly effective in minimizing elevations for genuine patients. In particular, the mixed diagnostic group produced only an average score (M = 54.75) with marginal elevations for patients with schizophrenia (M = 65.67) and PTSD (M = 68.40). Based on the normative data (see Table 5 ), the Ds clearly merits examination in clinical cases where feigning is suspected. In stark contrast to Ds, FBS also tries to capitalize on erroneous stereotypes but was designed for only circumscribed referrals (i.e., personal injury cases). Its general lack of success (mean d = .32) is likely attributable to its narrow focus.
Two additional detection strategies are obvious-subtle, and symptom selectivity. The obvious-subtle strategy as measured by O-S also produced a large effect size (mean d = 1.51). Its marked variation (i.e., SDs > 60) for genuine patients both within diagnoses and across diagnostic groups raises questions about the O-S's clinical applicability. Finally, LW as a measure of symptom selectivity yielded a large effect size (d = 1.27) that is substantially lower than most other feigning indexes. In addition, the usefulness of LW remains to be investigated with specific diagnostic groups. At present, both the O-S and LW appear to be very limited in their clinical applicability.
The current findings offer partial support for Greene's bipolarity hypothesis. Whereas the effect size for L was modest (d = .45), K had a moderate effect (d = .89). Based on Table 5 , most feigners do not have elevations on K (i.e., ≤ 55T). However, the magnitude of these effect sizes does not suggest that the absence of defensiveness effectively discriminates feigned from genuine profiles. Despite the lack of current clinical applicability, future research may wish to investigate the usefulness of specialized indicators, such as Wsd and Mp that appear more effective than the traditional L and K scales in the assessment of defensiveness .
A major concern for practitioners is whether certain diagnostic groups, such as bona fide patients with schizophrenia and PTSD, are likely to have markedly elevated scores on validity indicators (see Table 5 ). Such elevations are likely to lead to misclassifications. When simulators of these two disorders are compared with presumably genuine patients with the same disorders, large effect sizes are found on most feigning scales for both diagnoses (see Table 4 ). Despite these appreciable group differences, practitioners must be concerned about cut scores with different diagnostic groups.
Clinical Applications of Cut Scores
The establishment of accurate and consistent cut scores is the sine qua non of malingering classification. Because the previous MMPI and MMPI-2 meta-analyses yielded such divergent cut scores, many researchers in recent investigations are disinclined to report cut scores. As a result, the meta-analytic data in Table 6 represent only a modest expansion of the Rogers et al. (1994) results. Obviously, the same divergence of cut scores continues to be observed.
We augmented the cut scores with clinical data from the current study and Greene's (2000) tabulation of Caldwell's data set on more than 50,000 patients. In using a normative approach to clinical cut scores, the basic premise is that extreme scores are almost never observed in presumably genuine populations. For this purpose, we adopted a very stringent standard (98th percentile). The obvious limitation of this approach is that an unknown but presumably small percentage of clinical samples may be undetected cases of malingering. However, their inclusion in these normative estimates likely will decrease the number of false-positives found with these cut scores.
Combining across empirically derived and normative cut scores, the Fp appears to be the most effective scale in the assessment of feigning for three reasons. First, its empirically derived cut scores are more consistent (range from > 4 to > 9) than most feigning scales and yield good classification rates (M = 84.3%). Second, the normative cut scores also have a narrow range (i.e., Caldwell data = 7; current data = 8 [men] and 9 [women]) and are generally aligned with empirically derived cut scores (see Table 6 ). Third, these cut scores appear to be effective across disorders (see Table 5 ) and even moderately useful with the problematic diagnosis of PTSD. 4 The traditional F scale evidenced several important limitations for its cut scores. First and foremost, F exhibited marked variations in cut scores (i.e., raw scores from > 8 to > 30). As previously noted, genuine patients tended to have elevated F's (M = 65.70) with a wide distribution of scores (SD = 19.03). As a result, only extreme scores appear effective for the classification of feigning. Conservatively, the F > 24 derived from the Caldwell data would result in very few false-positives among genuine patients, including those in the current meta-analysis (see Table 5 ). However, for certain diagnostic groups (patients with PTSD, schizophrenia, and presumably other psychotic disorders), a cut score at the high end of the empirical data (i.e., F > 30) would appear prudent.
Most clinicians routinely evaluated Fb in the assessment of feigning. Because bona fide patients have moderate elevations (overall M = 71.34) and considerable variation (SD = 22.23), this scale appears to be confounded by genuine psychopathology. One hypothesis is that genuine patients' attention begins to falter during the latter portions of an MMPI-2 administration. Obviously, an inspection of MMPI-2 profiles for response consistency is essential with Fb elevations. Because extreme elevations can be observed in a substantial minority of presumably genuine patients, we do not recommend the routine use of Fb cut scores at the present time. Greene (2000) suggested caution in the use of F-K as a primary indicator of feigning because of its variability of cut scores and less efficiency than F elevations alone. The current review of F-K cut scores questions its routine clinical use. The extraordinary divergence of cut scores from -8 to 32 provides clinicians with little confidence that a consistent cut score could be achieved.
Ds, capitalizing on erroneous stereotypes, demonstrated a high level of consistency across cut scores (i.e., Ds > 35 raw). Based on the normative data, the same cut score is likely to produce very few (i.e., < 2%) falsepositives when combining the Caldwell and current data sets. When faced with challenging presentations (i.e., PTSD or psychotic), a slightly higher cut score (e.g., > 36 for men) may be warranted. Outperforming Dsr on effect sizes and consistency of cut scores, the Ds appears to be the premier specialized validity scale with its sophisticated strategy and minimal risk of false-positives.
O-S produced very large effect sizes, although they varied across diagnostic groups (see Table 4 ). We found marked variations for empirically derived cut scores (90T to 221T) that were markedly lower than normative cut scores (240 and 256). Like other indexes, we found extreme endorsement levels by presumptively genuine patients with PTSD (M = 182.24, SD = 71.79). The most prudent course of action is simply not to use O-S with any patients with PTSD histories. In addition, O-S is unlikely to be clinically useful except in rare cases of extreme endorsement levels.
Conclusions and Future Directions
The assessment of malingering is a multifaceted process bringing together different clinical methods and multiple indicators (Rogers, 1997) . Within this context, the MMPI-2 should not be used as the sole or primary measure of feigning. Instead, the MMPI-2 should be viewed as an important clinical method that incorporates several key detection strategies. Of these strategies, rare symptoms and erroneous stereotypes appear to hold the most promise.
The current meta-analysis suggests that the most effective scales are likely to combine different models of scale development (i.e., discriminant, normative, and rational methods) with specific strategies (e.g., rare symptoms and erroneous stereotypes). This conclusion is at odds with the more traditional approach to scale development for feigning indexes (i.e., the exclusively normative approach to F and Fb) and its redundant reliance on the same strategy (i.e., rare symptoms). A future direction would be an examination of models for scale development and/or strategies that extend beyond the MMPI-2 to other standardized measures of malingering. The theoretical framework for the assessment of malingering could be improved substantially if we knew which detection strategies and which methods of scale development resulted in accurate classifications.
The most important clinical finding from the current meta-analysis involves the usefulness of the Fp across settings and diagnoses. The Fp yielded strong effect sizes and comparatively consistent cut scores that appear useful across settings and diagnostic groups. Despite time-honored traditions, we recommend the Fp as the primary MMPI-2 scale for the assessment of feigning. When feign-ing is suspected, the Ds scale is strongly recommended because of its consistency of cut scores and low probability of false-positives.
The current findings raise several issues about the context of the evaluation. Clearly, the mere presence of litigation has only modest effects (mean d = .43) on validity indicators. Researchers employing a differential prevalence design have often assumed that the litigation substantially increases the likelihood of feigning. The current data question both the assumption and the use of this design in feigning research. Beyond litigation per se, forensic groups (even with child custody cases removed) have lower scores on validity scales than genuine patients in general (see Table 5 ). Indirectly, these combined results for litigation and forensic status cast doubt about the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition's (DSM-IV) (American Psychiatric Association, 2001) postulation that the mere context of forensic evaluations increases the likelihood of malingering.
As a future direction, we would like to see the current results tested via known-groups comparisons using either expert clinical judgment or standardized methods producing very few false-positives (e.g., Structured Interview of Reported Symptoms) (Rogers, Bagby, & Dickens, 1992) to cross-validate findings of MMPI-2 simulation research. Even with simulation studies, the incorporation of independent measures to evaluate feigning would be strongly advisable. At present, the anomalous results for PTSD samples on select feigning indexes are difficult to interpret. Do the marked elevations on O-S and Fb indicate that these scales are confounded by PTSD symptomatology? Conversely, do these marked elevations indicate that a small proportion of these samples may be engaged in feigning, which remains undetected? When using samples of convenience not systematically screened for feigning, researchers cannot confidently rule out either interpretation.
The past four decades of MMPI/MMPI-2 research have seen a steady rise in the sophistication of feigning research. With methodological improvements (Rogers & Cruise, 1998) and the systematic appraisal of detection strategies, MMPI-2 research is likely to make continued advances in the clinical assessment of malingering. NOTES 1. Interestingly, many simulators endorse only slightly more obvious than subtle Minnesota Multiphasic Personality Inventory-2 (MMPI-2) items. The use of T-score transformations dramatically increases the observed differences because obvious items occur less frequently than subtle items in the normative sample.
2. Feigning research typically produces substantial effect sizes. Therefore, we have adopted the following descriptive terms based on Cohen's d: ≥ .75 for "moderate," ≥ 1.25 for "large," and ≥ 1.75 for "very large."
